代谢性酸中毒与慢性肾脏病患者急性肾损伤相关
这项回顾性队列研究纳入两个北美慢性肾脏病G3-G5期队列(美国电子病历队列136,067例和曼尼托巴索赔队列34,957例),发现代谢性酸中毒(血清碳酸氢盐12至<22 mEq/L)与急性肾损伤风险升高相关,美国队列风险比1.57(95%CI 1.52-1.61),曼尼托巴队列风险比1.65(95%CI 1.58-1.73)。
要点
- 代谢性酸中毒与慢性肾脏病患者急性肾损伤风险升高相关,美国队列HR 1.57(95%CI 1.52-1.61)。
- 曼尼托巴队列中该关联同样存在,HR 1.65(95%CI 1.58-1.73)。
- 碳酸氢盐作为连续变量及多个亚组和敏感性分析中关联一致。
核心结论
- 代谢性酸中毒与慢性肾脏病患者急性肾损伤风险升高相关。
- 作者认为在代谢性酸中毒治疗研究中应将急性肾损伤作为结局考虑。
研究设计与样本
- 回顾性队列研究,使用电子健康记录和行政数据。
- 纳入两个北美慢性肾脏病G3-G5期队列:美国电子病历队列136,067例和曼尼托巴索赔队列34,957例。
- 主要暴露为代谢性酸中毒(血清碳酸氢盐12 mEq/l至<22 mEq/l)。
- 主要结局为急性肾损伤(采用ICD-9和10代码或基于改善全球肾脏病预后组织指南的实验室定义)。
- 应用Cox比例风险回归模型校正相关人口学和临床特征。
主要发现
- 美国电子病历队列中代谢性酸中毒与急性肾损伤相关,HR 1.57(95%CI 1.52-1.61)。
- 曼尼托巴索赔队列中代谢性酸中毒与急性肾损伤相关,HR 1.65(95%CI 1.58-1.73)。
- 血清碳酸氢盐作为连续变量时关联一致。
- 多个亚组和敏感性分析(包括校正白蛋白尿的分析)中关联一致。
关键数值与推荐
- 代谢性酸中毒定义:血清碳酸氢盐12 mEq/l至<22 mEq/l。
- 急性肾损伤定义:采用ICD-9和10代码或基于改善全球肾脏病预后组织指南的实验室定义。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Metabolic acidosis in patients with chronic kidney disease (CKD) results from a loss of kidney function. It has been associated with CKD progression, all-cause mortality, and other adverse outcomes. We aimed to determine whether metabolic acidosis is associated with a higher risk of acute kidney injury (AKI). METHODS: This was a retrospective cohort study. Using electronic health records and administrative data, we enrolled 2 North American cohorts of patients with CKD Stages G3-G5 as follows: (i) 136,067 patients in the US electronic medical record (EMR) based cohort; and (ii) 34,957 patients in the Manitoba claims-based cohort. The primary exposure was metabolic acidosis (serum bicarbonate between 12 mEq/l and <22 mEq/l). The primary outcome was the development of AKI (defined using ICD-9 and 10 codes at hospital admission or a laboratory-based definition based on Kidney Disease: Improving Global Outcomes guidelines). We applied Cox proportional hazards regression models adjusting for relevant demographic and clinical characteristics. RESULTS: In both cohorts, metabolic acidosis was associated with AKI: hazard ratio (HR) 1.57 (95% confidence interval [CI] 1.52-1.61) in the US EMR cohort, and HR 1.65 (95% CI 1.58-1.73) in the Manitoba claims cohort. The association was consistent when serum bicarbonate was treated as a continuous variable, and in multiple subgroups, and sensitivity analyses including those adjusting for albuminuria. CONCLUSION: Metabolic acidosis is associated with a higher risk of AKI in patients with CKD. AKI should be considered as an outcome in studies of treatments for patients with metabolic acidosis.
引用
- Zhu A, Whitlock RH, Ferguson TW, et al. Metabolic Acidosis is Associated With Acute Kidney Injury in Patients With CKD. Kidney Int Rep. 2022. PMID: 36217527. doi:10.1016/j.ekir.2022.07.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。